|
Re: Subsequent Study/Trial
|
11
|
Resverlogix Corp.
|
Apr 03, 2020 02:21PM
|
|
Re: Three Great Posts on Investor Village
|
10
|
Resverlogix Corp.
|
Oct 18, 2016 02:41PM
|
|
Re: Apabetalone’s Positive Impact on Pulmonary Arterial Hypertension Published in the American Journal of Respiratory and Critical Care Medicine
|
10
|
Resverlogix Corp.
|
Mar 17, 2022 07:58PM
|
|
FDA
|
8
|
Resverlogix Corp.
|
Sep 30, 2019 01:54PM
|
|
Re: Gut Feeling
|
8
|
Resverlogix Corp.
|
Oct 02, 2019 07:18PM
|
|
Re: Will RVX be bankrupt?
|
8
|
Resverlogix Corp.
|
Jun 04, 2020 09:06PM
|
|
Re: BearDown, Ledenfrog, Tundup and all other experts.....
|
8
|
Resverlogix Corp.
|
Oct 20, 2015 12:10AM
|
|
Re: Zenith AGM?
|
7
|
Zenith Epigenetics
|
Dec 22, 2020 06:16PM
|
|
Re: Apabetalone treatment reduces SARS-CoV-2 infectivity and completely prevents cardiac damage in a cytokine-storm model
|
7
|
Resverlogix Corp.
|
Mar 03, 2021 07:37PM
|
|
Re: This Covid 19 possibility has
|
7
|
Resverlogix Corp.
|
Mar 24, 2020 11:23PM
|
|
Re: Apabetalone’s Positive Effect on Hospitalized Patients Involving Heart Failure
|
7
|
Resverlogix Corp.
|
Jan 12, 2021 08:58PM
|
|
Re: Just my opinion
|
7
|
Resverlogix Corp.
|
Sep 10, 2015 10:15PM
|
|
Re: RSU's awarded
|
7
|
Resverlogix Corp.
|
Sep 19, 2019 08:33PM
|
|
Shake it Up!
|
6
|
Resverlogix Corp.
|
Dec 22, 2020 05:26PM
|
|
Re: ... unfinished business
|
6
|
Zenith Epigenetics
|
Oct 31, 2018 03:26PM
|
|
Re: Revised target market, indications, market potential? ... and some numbers?
|
6
|
Resverlogix Corp.
|
Jun 14, 2020 07:52PM
|
|
Re: Pretty much as expected
|
6
|
Resverlogix Corp.
|
Sep 16, 2019 06:36PM
|
|
Re: THAT is it
|
6
|
Resverlogix Corp.
|
Nov 10, 2016 07:08PM
|
|
Re: 3 cheers for Don and the RVX team
|
6
|
Resverlogix Corp.
|
Feb 03, 2020 08:37PM
|
|
Re: 3 cheers for Don and the RVX team
|
6
|
Resverlogix Corp.
|
Feb 03, 2020 09:03PM
|
